期刊文献+

非酒精性脂肪性肝病的运动处方制定 被引量:6

Exercise prescription for non-alcoholic fatty liver disease
原文传递
导出
摘要 非酒精性脂肪性肝病(NAFLD)是世界范围内最常见的慢性肝病病因,且发病率逐渐上升,是多种心血管疾病、糖尿病和慢性肾病的危险因素,因此,非酒精性脂肪性肝病的防治非常重要。虽然运动疗法作为一种治疗手段已被证实对非酒精性脂肪性肝病的相关危险因素有改善作用,但不同的运动疗法对非酒精性脂肪性肝病的作用还需更多证据。进一步的研究和实践应基于运动处方的制定,探索不同运动处方治疗非酒精性脂肪性肝病的安全性和疗效。 Non-alcoholic fatty liver disease(NAFLD),which is a risk factor for multiple cardiovascular diseases,diabetes mellitus and chronic kidney disease,is the most common cause of chronic liver disease worldwide.The morbidity of NAFLD is increasing gradually.Therefore,it becomes more and more important to prevent and treat nonalcoholic fatty liver disease.Exercise therapy,as a therapeutic method,has been proven to improve nonalcoholic fatty liver disease by a large number of studies.This article reviews the effect of exercise therapy on non-alcoholic fatty liver,the formulation principle of exercise prescription and the therapeutic effect of exercise therapy on non-alcoholic fatty liver related risk factors,which may provide reference for exercise intervention in the treatment of nonalcoholic fatty liver disease.
作者 张亚男 范竹萍 范建高 ZHANG Ya-nan;FAN Zhu-ping;FAN Jian-gao(Renji Hospital Affiliated to Medical College of Shanghai Jiaotong University,Shanghai 200025,China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2019年第3期222-226,共5页 Chinese Journal of Practical Internal Medicine
基金 上海市加强公共卫生体系建设三年行动计划(第四轮)重点学科项目资助
关键词 非酒精性脂肪性肝病 运动疗法 运动处方 心血管疾病 糖尿病 non-alcoholic fatty liver disease exercise therapy exercise prescription cardiovascular diseases diabetes mellitus
  • 相关文献

参考文献2

二级参考文献47

  • 1Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
  • 2Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
  • 3Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
  • 4Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
  • 5Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
  • 6Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
  • 7Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
  • 8Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
  • 9Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].
  • 10Than NN, Newsome PN. A concise review of non-alcoholicfatty liver disease. Atherosclerosis 2015; 239: 192-202 [PMID:25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001].

共引文献332

同被引文献78

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部